Tribute to Eugene Braunwald, MD, MACC, D.Sc.: Father of Clinical Cardiology

Remember Me To the living, I am gone, To the sorrowful, I will never return, To the angry, I was cheated, But to the happy, I am at peace, And to the faithful, I have never left. -Margaret Mead THE JOURNEY Eugene Braunwald (August 15, 1929 –April 22, 2026), beloved devout cardiologist, dedicated teacher, dutiful mentor, decisive editor, diligent researcher par excellence, left to his heavenly abode on April 22, 2026, at the age of 96 years, “Father of Clinical Cardiology.” In the hall of fame, he joins other all-time greats in medicine and cardiology – Andreas Grüntzig (Father of Interventional Cardiology), Dwight Emary Harken (Father of Heart Surgery), Paul Dudley White (Father of Preventive Cardiology), Sir William Osler (Father of Modern Medicine), William Harvey (Father of Circulation), and Hippocrates (Father of Medicine). This article is a small tribute to Prof Eugene Braunwald Figure 1 as well as other pioneers in the hall of fame of medicine and cardiology Table 1.Figure 1: Professor Eugene Braunwald MD, MACC, D.Sc.: Father of Clinical Cardiology (August 15, 1929–April 22, 2026), Distinguished Hersey Professor of Medicine and Physic (Harvard Medical School), Founding Chairman, TIMI Study Group (Brigham and Women’s Hospital), Founding Chair of the Department of Medicine: University of California, San Diego (1968–1972), Chair of the Department of Medicine: Brigham and Women’s Hospital (1972–1996), Chief of Cardiology and Clinical Director: National Heart, Lung and Blood Institute (1957–1968)Table 1: Pioneers in cardiology – Modern, medieval, ancient, and primitiveKasliwal’s team at the prestigious All India Institute of Medical Sciences and Medanta Heart Institute enjoyed a privileged and foundational association with Eugene Braunwald’s renowned Thrombolysis in Myocardial Infarction (TIMI) Study Group from its very inception in 1984. This seamless collaboration over the decades has contributed to immense advancements in cardiovascular medicine, leading to publications in prestigious high-impact journals. The TIMI Group, known for rigorous clinical trials and groundbreaking research, has been instrumental in addressing critical issues in heart health, which helped drive improvements in patient care, contributing to the academic and clinical success that characterizes the TIMI Group’s legacy.1,2 In March 1938, at age 8, his idyllic childhood was interrupted by the 1938 Nazi Anschluss (annexation) of Austria, forcing his family to escape to England in July 1938, where he lived on a farm experiencing severe hardships. During World War II, he and his younger brother Jack were evacuated from London to a farm in northern England before immigrating to New York in 1939. He overcame the trauma of displacement, later describing it as shaping his work ethic. He was educated in the New York public school system, graduating as class valedictorian. He attended New York University (NYU), earning his Bachelor’s degree (A.B.) magna cum laude. He was the youngest student admitted to his class at NYU Medical School, from which he graduated in 1952, earning the highest marks in his class. As a student, he initially considered engineering but was guided by his mother toward medicine. He completed his internal medicine residency at Johns Hopkins Hospital and later worked in the laboratory of Nobel laureate André Cournand at Columbia University. His interest in cardiology was solidified during his time as a student at the Bellevue Cardiology Clinic under Ludwig Eichna. Eugene Braunwald (1929–2026), widely revered as the Father of Clinical Cardiology, revolutionized cardiovascular medicine by shifting the clinical approach from passive observation to active, time-sensitive intervention. Over a seven-decade career spanning the NIH, UC San Diego, and Harvard Medical School, he mentored generations of leaders and authored Braunwald’s Heart Disease, the defining textbook for the field. THREE AHA MOMENTS Eugene Braunwald (1929–2026), experienced several “aha!” moments. These incidences have reshaped how cardiovascular medicine is practiced worldwide. The three “aha!” moments in his career include: Heart attacks are gradual “dimmer switch” revelation The concept of “Dimmer Switch” originated in the 1960s and not an instantaneous event—similar to turning off a light switch. Braunwald work supported the dimmer switch hypothesis. His team proved that heart muscle damage though progressive was also treatable. His team showed that ischemic tissue could be salvaged before dying irreversibly. This has lead to the foundational concepts of “open artery” theory, the entire field of early reperfusion therapies, infarct size reduction and most importantly “time is muscle” dictum. His work has lead to numerous life-saving interventions, thrombolytic therapies. catheter-based revascularization procedures. Identifying hypertrophic cardiomyopathy In the late 1950s, doctors were puzzled by patients with heart obstruction that did not fit the traditional mold of valvular heart disease. Braunwald et al. studied cases involving a severe, idiopathic thickening of the heart walls that caused obstruction. They defined the clinical entity now known as hypertrophic cardiomyopathy in a 1964 monograph. Their work allowed doctors to identify and treat this condition, which is a significant cause of sudden cardiac death, particularly in young athletes.3,4 Founding the Thrombolysis in Myocardial Infarction Study Group He supported large trials to individual case studies especially for the purpose of deciphering the complex mechanisms of ischemia during a heart attack. This led to the logical establishment of the Thrombolysis In Myocardial Infarction (TIMI) Study Group in 1984. This has led to the dawn of rigorous, evidence-based medicine. The group’s extensive research has directly enabled physicians to identify and treat conditions responsible for sudden cardiac death, particularly in young athletes. Spanning over 80 trials and involving more than 450,000 patients, the TIMI Study Group has established the foundational evidence for vital medical interventions, including statins, modern antiplatelet therapies, and clot-busting thrombolysis.5,6 HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY In the late 1950s, a 28-year-old Eugene Braunwald was in the right place – the new NIH Clinical Center – at the right time. He did not just find a new heart disease; he birthed our understanding of it – hypertrophic obstructive cardiomyopathy (HOCM). While surgeons expected a “discrete” blockage, they kept seeing thick, stubborn muscle clogging the heart, not a leaky valve. It was a real “aha!” moment, proving the heart was not just broken; it was overgrown – HOCM. Eugene Braunwald did not let the grass grow under his feet, realizing this was not a rare oddity but a common genetic rebel. Andrew Glenn Morrow (the surgeon) initially thought Eugene Braunwald “messed up,” but soon, they were seeing it everywhere. Eugene Braunwald defined its “dynamic” nature – how the muscle tightened under stress. He proved it was not just a “stone in the pipe,” but a changeable, sneaky actor. This was the birth of modern HOCM care, showing that while you cannot judge a book by its cover, you can absolutely fix a heart by its septum. He and Andrew Glenn Morrow turned a fatal enigma into a manageable, well-understood condition. It is a “time is muscle” story, with Eugene Braunwald leading the charge! The birthing of HOCM is a genetic “family affair.” Often, it is inherited – a 50% chance from a parent. Think of it as a DNA recipe gone slightly rogue, causing the heart muscle to “hit the gym” way too hard. It usually starts during adolescence or young adulthood. The wall between the lower chambers – the septum – becomes too thick. It is the classic “overachiever” muscle. This thickening makes the heart “stiff.” It cannot relax to fill with blood. Then, this bulky muscle bulges, causing an obstruction. Usually, the thickened septum poses a static physical obstruction to the outward flowing blood. Then there is a dynamic obstruction component in the form of systolic anterior motion (SAM) of the anterior mitral leaflet. There can be associated significant “mitral regurgitation,”. This increased workload can often lead to fatigue or chest pain. . Essentially, the heart is “all heart” but has no room to move. TIME IS MUSCLE CONCEPT Eugene Braunwald, coined the phrase “Time is Muscle”, a foundational that has changed the way myocardial infarction (MI) is managed worldwide. He realized that damage is not instantaneous – it is a slow, progressive, ticking clock, similar to a turning a dimmer switch rather than an instantaneous light switch. In short – every second counts, so do not wait. Think of it as a race – the longer the artery stays blocked, the more muscle dies, eventually turning into a scarred, weak heart. When ischemia kicks in, the heart is, quite literally, losing its grip. “Time is muscle” taught us to act fast, opening clogged vessels through urgent reperfusion (stenting or drugs) to salvage that crucial, myocardium. If a heart attack strikes, the early bird gets the worm – and keeps the heart muscle. If you wait, you lose. It is all about protecting the myocardium. In short, prompt action is the best action, proving that when it comes to cardiac care, time is, indeed, muscle. In 1984, Dr. Eugene Braunwald looked at heart attacks and decided it was time to stop just waiting and start breaking. Thus, the TIMI trials were born, turning cardiology on its head. Eugene Braunwald, often called the “Father of Clinical Cardiology,” did not just make waves; he created a sea change in how we treat broken hearts. TIMI-1 showed that tissue plasminogen activator was better at busting clots than old-school streptokinase, saving precious muscle. “Time is muscle,” Eugene Braunwald argued, and the trials proved it by treating faster, preventing the heart from becoming a “gone to pieces” wreck. They did not stop there. Over 40 years, TIMI studies tackled cholesterol with statins and introduced essential blood thinners, making them the “gold standard” in clinical research. With >80 trials and 450,000 + patients, Eugene Braunwald’s team did not just walk; they ran the marathon to improve patient care, showing that when it comes to the heart, it is best to be “fast, not furious.” His legacy was simple: “We are privileged to work in a field where what we do today can be better than what we did yesterday.”5,6 LEFT VENTRICULAR EJECTION FRACTION Eugene Braunwald, the “Father of Clinical Cardiology,” did not just look at the heart; he made it tell its secrets. Back in the early 1960s, he realized we needed a better way to assess the heart’s pumping power than just “vibe checks.” Enter the left ventricular ejection fraction (LVEF), a metric that became the golden ticket of cardiology.7 However, here is the nuance: EF is not everything. It is just systolic function (the squeeze). You can have a normal EF but a “stiff” heart that will not fill, proving that just because you have a good ejection, does not mean your circulation is fine. Braunwald’s genius was showing that keeping this fraction high after a heart attack is crucial for survival. He proved that measuring this “LVEF” helps turn heart failure from a dead-end into a manageable condition. BRAUNWALD’S HEART DISEASE: A TEXTBOOK OF CARDIOVASCULAR MEDICINE The book was first published in 1980 and has since been regularly updated to reflect rapidly changing clinical science, now often in its 12th or 13th edition. This award-winning, two-volume text serves trainees and seasoned cardiologists worldwide, offering evidence-based, state-of-the-art guidance on everything from molecular biology and imaging to complex interventional techniques. It is renowned for combining basic science with clinical application, providing an unparalleled, frequently updated multimedia resource, and is popularly known as “Bible of Cardiology.” BRAUNWALD’S FAMOUS FIVE APHORISMS “Time is myocardium.” The core of the current approach to ST-segment elevation MI “The greatest mistake in medicine is to treat the diagnosis rather than the patient” “Basic and clinical research are the twin engines of progress in medicine” “The future of medicine lies in personalized care, guided by genomics, proteomics, and deep phenotyping” “We have gone from an era of descriptive cardiology to one of mechanistic understanding and now to targeted therapies. This is nothing short of a revolution.” Eugene Braunwald (1929–2026) established a monumental 74-year career defined by unparalleled productivity and transformative impact. Beginning his research in 1954, he authored up to 1800 peer-reviewed articles, becoming one of the most cited cardiologists in history. He has made many foundational and pioneering contributions to cardiology. This has shifted the MI condition from a near-certain fatal diagnosis into a highly manageable condition.8,9 An ode to Eugene Braunwald: Father of Clinical Cardiology Born in difficult times, with only Holocaust to blame, Turned adversity and pain to power and fame. Though engineering stirred his bright and curious soul, Medicine called louder and became his lifelong goal. He gave us ejection fraction – the ventricle’s report card true, HOCM’s secrets too, he cracked right through. “Time is muscle,” he said – don’t wait, don’t fumble, don’t bungle! In heart attacks, every minute makes trouble double. Eugene Braunwald – what a mighty name, “Legend” sounds too little; “icon” feels lame. And “Institution” just the same, Father of Clinical Cardiology, his timeless claim. Beside him stands Andreas Grüntzig, bold, Father of interventional cardiology, a story oft told. With balloon angioplasty, he opened the way, Saving countless hearts to this very day. Dwight Emary Harken, a surgeon of skill, Father of heart surgery, bending the will. He removed all the shrapnel in war’s dark night, Proving the heart could handle the fight. Paul Dudley White, with a bicycle fast, Father of preventive cardiology, a shadow he cast. Advocating for exercise, lifestyle, and diet, Bringing cardiac rehabilitation quiet. Sir William Osler, in wisdom so deep, Father of modern medicine, promise to keep. At the bedside he taught, with a clinical eye, A standard of care that never shall die. William Harvey, the truth to reveal, Father of circulation, with passion and zeal. He traced how the blood moves, a pump in the chest, Physiology’s master, passing the test. Hippocrates, ancient, a pillar so high, Father of medicine, beneath the blue sky. With his oath to the patient, he laid the foundation, A legacy lasting for every nation. Author contribution The authors contributed equally. Financial support and sponsorship Nil. Conflicts of interest There are no conflicts of interest.